Singapore: Aslan Pharma raises US$20m from a PP with potential to raise another US$80m

By
Nick Herbert
-
SINGAPORE-MARCH 19 : The Merlion and the Marina Bay Sands Resort Hotel, billed as the world's most expensive standalone casino property at S$8 billion on March 19, 2013 in Singapore. (SINGAPORE-MARCH 19 : The Merlion and the Marina Bay Sands Resort Ho

Nasdaq listed Aslan Pharmaceuticals, a clinical-stage immunology-focused biopharmaceutical company, with teams in California and Singapore, has raised approximately US$20m in a private placement to BVF Partners, K2 HealthVentures and certain existing investors. In addition, Aslan will have the potential to receive up to an additional US$80m if all purchase warrants also being issued in connection…

You must be a HMI Subscriber to view this content.

Subscribe Now »

RELATED ARTICLESMORE FROM AUTHOR